A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D.
Jung-Yun LeeJae-Weon KimMyong Cheol LimSunghoon KimHee Seung KimChel Hun ChoiJu Yeon YiSang-Yoon ParkByoung Gie Kimnull nullPublished in: Journal of gynecologic oncology (2020)
ClinicalTrials.gov Identifier: NCT03899610.